IMMUNO-ONCOLOGY

Braving the Complexities of
Immuno-Oncology Trials

 

ABSTRACT

EVOLVING INDUSTRY

TRIAL DESIGNS

CHALLENGES

MANY SOLUTIONS

ABSTRACT

Immuno-oncology trials are increasing in prevalence and, for many reasons, are much more complex than standard clinical trials. Shipping, with short timelines, strict conditions for maintaining sample integrity, and the need for detailed, international tracking, is complicated. Sponsors must navigate unfamiliar, area-specific standards and regulations to perform site development and local lab evaluations. Once the study is underway, large quantities of data must be processed and shared. Partnering with an experienced central lab can alleviate these challenges, create efficiencies, and save researchers time and expense.

Unlock the Full White Paper

Immuno-oncology therapies are gaining great momentum in the field of oncology. The approach of personalized medicine is revolutionizing cancer treatment and, as a result, clinical trials are becoming more and more complex. Read this white paper to learn about how the industry is changing, what the challenges are, and what solutions are available.  

 

ABSTRACT

EVOLVING INDUSTRY

TRIAL DESIGNS

CHALLENGES

MANY SOLUTIONS